Sagetis to attend CLINAM 2015

June 1, 2015

Barcelona, June 2015 – Sagetis Biotech, S.L. announces today that Dr. Salvador Borrós, Sagetis' CSO, will be attending the 8th European Summit for Clinical Nanomedicine and Targeted Medicine, which will take place in Basel this year.

 

In addition to attending the scientific program, Dr. Borrós will participate in a Keynote Session titled "Peptide‐functionalized Nanoparticles as Dual Targeting Drug Delivery System for Brain Tumors Therapy" and will be glad to speak with other participants to explore potential scientific and business collaborations.

 

About CLINAM

 

The European Foundation for Clinical Nanomedicine is a non-profit institution aiming at advancing medicine to the benefit of individuals and society through the application of nanoscience. Aiming at prevention, diagnosis, and therapy through nanomedicine as well as at exploration of its implications, the Foundation reaches its goals through support of clinically focused research and of interaction and information flow between clinicians, researchers, the public, and other stakeholders.

 

 

 

Share on Facebook
Share on Twitter
Please reload

Featured Posts

SAGETIS BIOTECH GRANTS EXCLUSIVE LICENSE OF ITS VIROSHIELD TECHNOLOGY TO ARATINGA.BIO TNP FOR RETROVIRAL AND PLASMID-BASED APPLICATIONS

March 29, 2019

1/4
Please reload

Recent Posts
Please reload

© 2018 - Sagetis Biotech | Via Augusta 394 –  08017 - Barcelona (SPAIN)

www.sagetis-biotech.com | Privacy Policy